- Home
- / Edge Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Edge Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
CreditSafe Score
?
Score changed on Jun 16, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
|---|---|---|---|---|---|---|---|
| General and administrative expense | 8.7M | 14.7M | 17.7M | 14.3M | 11.0M | 7.0M | 10.2M |
| Operating expense total | 26.5M | 39.5M | 52.0M | 40.3M | 17.1M | ||
| Depreciation and amortization | 15.6K | ||||||
| EBIT | (26.5M) | (39.5M) | (52.0M) | (43.1M) | (21.0M) | (14.9M) | (21.4M) |
| Investment income | 9.1K | 212.3K | 700.9K | 871.9K | |||
| Interest income | 353.5K | 55.0K | 4.3K | ||||
| Pre tax profit | (29.2M) | (40.7M) | (53.4M) | (43.6M) | (7.4M) | (14.8M) | (21.4M) |
| Income tax expense | (1.1M) | (1.8M) | (2.6M) | (2.8M) | 381.5K | (4.5M) | |
| Net Income | (28.1M) | (38.8M) | (50.9M) | (40.9M) | (7.0M) | (14.8M) | (16.9M) |